← Back to all trials
Not Yet Recruiting
NCT05721326
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Conditions: Genetic Predisposition to Disease, Breast Cancer Female, Ovarian Cancer, Hereditary Breast and Ovarian Cancer, Hereditary Cancer Syndrome, Hereditary Diseases, Gene Mutation-Related Cancer
Sex: Female
Ages: 25 Years – 100 Years
Phase: NA
Enrollment: 450
Sponsor: Abramson Cancer Center of the University of Pennsylvania
Location: United States
Summary
The goal of this sequential study design is to increase genetic testing in those meeting national clinical guidelines.
The main question it aims to answer is: which intervention is most effective in uptake of genetic testing for the target population?
Participants will receive genetic testing and counseling that may initiate life-saving screenings.
Eligibility Criteria
Inclusion Criteria:Patients with serous ovarian cancer diagnosed more than two years prior to study contactPatients with breast cancer diagnosed at <50 years of age more than two years prior to study contactPatients with triple negative breast cancer diagnosed more than two years prior to study contactUnaffected individuals reporting a family history of ovarian cancerUnaffected individuals reporting a family history of male breast cancerUnaffected individuals reporting a family history of breast cancer <50 yearsExclusion Criteria:1. Patients who have previously received genetic counseling and/or testing
Source: ClinicalTrials.gov (NCT05721326). StuddyBuddy aggregates publicly available trial information.
